|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- September 29, 2008
CopyrightCOPYRIGHT 2008 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
4-Antibody AG, of Basel, Switzerland, appointed Richard Mason CEO. Mason previously served as executive-in-residence at venture capital firm Advent Venture Partners.
Alpharma Inc., of Bridgewater, N.J., said its board unanimously rejected the unsolicited tender offer by Bristol, Tenn.-based King Pharmaceuticals Inc. to acquire all of Alpharma's outstanding shares at $37 per share. The company urged shareholders not to tender shares and called King's offer financially inadequate. Earlier this month, King opted to go hostile in its bid to buy Alpharma in a deal valued at $1.6 billion. In response to Alpharma, King argued that its offer was the only offer and it was ...